These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19225146)

  • 81. Effect of daily linear acceleration training on the hypergravity-induced vomiting response in house musk shrew (Suncus murinus).
    Abe C; Iwata C; Shiina T; Shimizu Y; Morita H
    Neurosci Lett; 2011 Sep; 502(3):138-42. PubMed ID: 21741451
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
    Rojas C; Raje M; Tsukamoto T; Slusher BS
    Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.
    Suzuki K; Yamanaka T; Hashimoto H; Shimada Y; Arata K; Matsui R; Goto K; Takiguchi T; Ohyanagi F; Kogure Y; Nogami N; Nakao M; Takeda K; Azuma K; Nagase S; Hayashi T; Fujiwara K; Shimada T; Seki N; Yamamoto N
    Ann Oncol; 2016 Aug; 27(8):1601-6. PubMed ID: 27358385
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Emerging treatments in chemotherapy-induced nausea and vomiting.
    Grunberg SM; Slusher B; Rugo HS
    Clin Adv Hematol Oncol; 2013 Feb; 11(2 Suppl 1):1-18; quiz 2 p following 18. PubMed ID: 23598819
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
    Eisenberg P; Figueroa-Vadillo J; Zamora R; Charu V; Hajdenberg J; Cartmell A; Macciocchi A; Grunberg S;
    Cancer; 2003 Dec; 98(11):2473-82. PubMed ID: 14635083
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The efficacy of aprepitant and palonosetron on cisplatin doublet in lung cancer].
    Suzuki C; Hiura K; Sato H; Komori H; Yamamoto M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1653-7. PubMed ID: 21996961
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thermoregulatory correlates of nausea in rats and musk shrews.
    Ngampramuan S; Cerri M; Del Vecchio F; Corrigan JJ; Kamphee A; Dragic AS; Rudd JA; Romanovsky AA; Nalivaiko E
    Oncotarget; 2014 Mar; 5(6):1565-75. PubMed ID: 24728971
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Exploring the role of ghrelin and des-acyl ghrelin in chemotherapy-induced nausea and vomiting.
    Yang L; Kung CJS; Lu Z; Liu JYH; Ngan MP; Sakai T; Sakata I; Chan SW; Tu L; Rudd JA
    Neuropharmacology; 2024 Jun; 251():109919. PubMed ID: 38548221
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.
    Hothersall JD; Moffat C; Connolly CN
    Br J Pharmacol; 2013 Jul; 169(6):1252-62. PubMed ID: 23581504
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.
    Fujiwara-Sawada M; Imanishi T; Yoshida A; Baba J
    J Pharm Pharmacol; 2003 Feb; 55(2):271-4. PubMed ID: 12631420
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats.
    Leon RM; Borner T; Stein LM; Urrutia NA; De Jonghe BC; Schmidt HD; Hayes MR
    Neuropharmacology; 2021 Apr; 187():108477. PubMed ID: 33581143
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
    Rock EM; Kopstick RL; Limebeer CL; Parker LA
    Br J Pharmacol; 2013 Oct; 170(3):641-8. PubMed ID: 23889598
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.
    Jaime-Lara RB; Borner T; Holland RA; Shaulson E; Brooks B; De Jonghe BC
    Biol Res Nurs; 2021 Oct; 23(4):584-595. PubMed ID: 33789505
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.
    Ullah I; Subhan F; Ayaz M; Shah R; Ali G; Haq IU; Ullah S
    BMC Complement Altern Med; 2015 Feb; 15():34. PubMed ID: 25888212
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Comparative Study of the Antiemetic Effects of α
    Sun Y; Darmani NA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731821
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.
    Huang D; Meyers K; Henry S; De la Torre F; Horn CC
    J Neurosci Methods; 2011 Apr; 197(2):249-58. PubMed ID: 21392533
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews.
    Horn CC; Meyers K; Pak D; Nagy A; Apfel CC; Williams BA
    Physiol Behav; 2012 Jun; 106(4):562-8. PubMed ID: 22504494
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Food restriction, refeeding, and gastric fill fail to affect emesis in musk shrews.
    Horn CC; Still L; Fitzgerald C; Friedman MI
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G25-30. PubMed ID: 19892939
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antiemetic effects of baclofen in a shrew model of postoperative nausea and vomiting: Whole-transcriptome analysis in the nucleus of the solitary tract.
    Konno D; Sugino S; Shibata TF; Misawa K; Imamura-Kawasawa Y; Suzuki J; Kido K; Nagasaki M; Yamauchi M
    CNS Neurosci Ther; 2022 Jun; 28(6):922-931. PubMed ID: 35238164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.